Enhancing intestinal drug solubilisation using lipid-based delivery systems.
about
Curcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast CancerModels for Predicting Drug Absorption From Oral Lipid-Based FormulationsPharmacokinetic aspects and in vitro-in vivo correlation potential for lipid-based formulationsModulating Drug Release and Enhancing the Oral Bioavailability of Torcetrapib with Solid Lipid Dispersion Formulations.Effect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.Self-microemulsifying drug delivery system for improving the bioavailability of huperzine A by lymphatic uptake.Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity.The preparation of 3,5-dihydroxy-4-isopropylstilbene nanoemulsion and in vitro release.Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions.Improved oral bioavailability in rats of SR13668, a novel anti-cancer agent.Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulationsIn vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate.Fabrication of lipidic nanocarriers of loratadine for facilitated intestinal permeation using multivariate design approach.Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex.Development, characterization, and in vitro evaluation of tamoxifen microemulsions.Lacidipine self-nanoemulsifying drug delivery system for the enhancement of oral bioavailability.Improvement of oral availability of ginseng fruit saponins by a proliposome delivery system containing sodium deoxycholateExperimental design-based optimization of lipid nanocarrier as delivery system against Mycobacterium species: in vitro and in vivo evaluation.Lipid-Based Drug Delivery Systems.Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal.How nanotechnology can enhance docetaxel therapy.Computational prediction of drug solubility in lipid based formulation excipients.Advances in the pulmonary delivery of poorly water-soluble drugs: influence of solubilization on pharmacokinetic properties.Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.Diverse approaches for the enhancement of oral drug bioavailability.Oral formulation strategies to improve solubility of poorly water-soluble drugs.Overview of drug product development.Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).Bioaccessibility of nutrients and micronutrients from dispersed food systems: impact of the multiscale bulk and interfacial structures.Transforming lipid-based oral drug delivery systems into solid dosage forms: an overview of solid carriers, physicochemical properties, and biopharmaceutical performance.Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticals.Self-microemulsifying drug delivery system (SMEDDS)--challenges and road ahead.Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.Oral bioavailability: issues and solutions via nanoformulations.Theory and practice of supersaturatable formulations for poorly soluble drugs.Novel Nanostructured Solid Materials for Modulating Oral Drug Delivery from Solid-State Lipid-Based Drug Delivery Systems.The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.
P2860
Q26744566-386B17AF-380A-4BC0-8AB5-006F6A326E2CQ26776481-B66ADC47-8AEE-4F88-B444-C0ADD7557544Q28084784-74693750-1397-4086-A1BF-4323A0413C93Q30390764-C29930A8-0B1F-4CEB-84B1-39CF18FFE998Q33681221-47C342F9-756B-4098-B409-0D850BF6DD7CQ33682598-2E4F7ACC-71F9-439D-8217-9EE03C3FAAE9Q33713176-E67E3046-9226-4C2B-ABB5-9185653D53A3Q33932992-B92B4FC2-1496-4830-9D6C-00608F977BC0Q33952771-C159DEEA-1484-4E7F-A35D-64E85D0B641BQ34700430-3D99C3FA-FABF-4C4C-839D-0994CBC92F7CQ34701702-4A9D45FB-9FFC-4A37-9114-DB44D9BBFAFEQ34704317-249F3D4A-03B5-4546-A386-970F09AA72FFQ35136316-8D0E513B-651A-4F88-9CAD-2FE2B6B3A8DEQ35667693-5B12A500-18FA-4654-9981-25C455D44D7EQ35677172-46300E52-2A57-48D2-A7F4-5211BBBE9BBEQ35681427-6171B4FB-1782-4559-80AA-A417D4EE96ABQ35771256-C8FC897C-9CA4-4797-A6A6-35F90BE1D162Q35917912-A469F299-3DB5-4D59-8DBC-435A5C1D3B0BQ36092898-CC653DDB-5A53-41F4-B893-9C330E41AAD1Q36112195-DFE90A60-0360-42F1-9F93-18D4D98AA82CQ36148640-EB882AF5-17F3-4EEF-A5D4-5BB9A1986675Q37091683-DC8F45CD-5A55-41AA-9BEC-984399ACD411Q37345633-92EB8ADD-D122-4E2A-AE90-AD3E6DBA728DQ37565681-41A8847A-EB3D-4849-A91A-CEC2C00C00E8Q37702234-ABF9F0B3-38F1-44DD-BD1A-F07FCEE3483BQ37805592-B9E74059-182A-4D09-92DD-3DC84EC59971Q37863645-E2A20019-A09A-4B5F-BB48-20C8F8EF2599Q37910262-4AEB3D96-AB15-496A-9E39-F4DBD2CA4300Q37965423-3DAF8064-D463-4BFD-8C02-2410CE7BE487Q37988960-E9883146-33AB-4732-B0D4-6557E56907B5Q38049354-74B801E3-E3EB-4AD7-BC4C-B0CFC46E612DQ38115195-00E5D1B7-99F0-4001-BD4A-B68239229CC7Q38119168-D1A950C5-3078-43E2-854D-497D18DFE7F6Q38123857-C144F897-AFA4-496B-8EA0-749694817550Q38199539-865DA4C2-8399-4A26-AAF3-67EC06AE1868Q38306645-63FAFB1A-BEF7-46AB-8E12-CE74B1B741FAQ38349734-B08AC1FF-872E-45CB-80EC-D7D798779F54Q38411345-B1B5C9A5-26A1-42B0-85D7-C46BA7DD4540Q38583850-B197E75C-0E4C-4B3B-87C8-F9D21F8C9A0DQ38644728-271DBD3F-295D-41A8-A4B4-9407BEC5AD30
P2860
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
@en
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
@nl
type
label
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
@en
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
@nl
prefLabel
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
@en
Enhancing intestinal drug solubilisation using lipid-based delivery systems.
@nl
P2093
P1476
Enhancing intestinal drug solubilisation using lipid-based delivery systems
@en
P2093
Colin W Pouton
Jean F Cuine
William N Charman
P304
P356
10.1016/J.ADDR.2007.10.014
P407
P577
2007-11-07T00:00:00Z